Agrawal G (2021) On pins and needles: tracking COVID-19 vaccines and therapeutics

Baas J, Senninger N, Elser H (1994) Das retikuloendotheliale System. Eine Ubersicht über Funktion, Pathologie und neuere Messmethoden [The reticuloendothelial system. An overview of function, pathology and recent methods of measurement]. Zeitschrift fur Gastroenterologie 32(2):117–123

CAS  Google Scholar 

Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S (2016) Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release 238:176–185. https://doi.org/10.1016/j.jconrel.2016.07.051

Article  CAS  Google Scholar 

Barbaro G, Scozzafava A, Mastrolorenzo A, Supuran CT (2005) Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Des 11(14):1805–43

Article  CAS  Google Scholar 

Bharti C, Nagaich U, Pal AK, Gulati N (2015) Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharma Investig 5(3):124–133. https://doi.org/10.4103/2230-973X.160844

Article  CAS  Google Scholar 

Bolhassani A (2023) Lipid-based delivery systems in development of genetic and subunit vaccines. Mol Biotechnol 65(5):669–698. https://doi.org/10.1007/s12033-022-00624-8

Article  CAS  Google Scholar 

Chenthamara D, Subramaniam S, Ramakrishnan SG, Krishnaswamy S, Essa MM, Lin FH, Qoronfleh MW (2019) Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res 23:20. https://doi.org/10.1186/s40824-019-0166-x

Article  CAS  Google Scholar 

Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 57:279–83

Article  CAS  Google Scholar 

Courrier HM, Butz N, Vandamme TF (2002) Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst 19(4–5):425–498. https://doi.org/10.1615/critrevtherdrugcarriersyst.v19.i45.40

Article  CAS  Google Scholar 

Davis ME, Chen Z, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discovery 7(9):771–782

Article  CAS  Google Scholar 

Desai AD, Lavelle M, Boursiquot BC, Wan EY (2022) Long-term complications of COVID-19. Am J Physiol Cell Physiol 322(1):C1–C11. https://doi.org/10.1152/ajpcell.00375.2021

Article  CAS  Google Scholar 

Diebold SS, Kursa M, Wagner E, Cotten M, Zenke M (1999) Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 274(27):19087–19094. https://doi.org/10.1074/jbc.274.27.19087

Article  CAS  Google Scholar 

Drożdżal S, Rosik J, Lechowicz K, Machaj F, Kotfis K, Ghavami S, Łos MJ (2020) FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat 53:100719. https://doi.org/10.1016/j.drup.2020.100719

Article  Google Scholar 

Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y (2022) Advances in COVID-19 mRNA vaccine development. Sig Transduct Target Ther 7(1):94. https://doi.org/10.1038/s41392-022-00950-y

Article  CAS  Google Scholar 

Gautret P, Lagier JC, Parola P, Meddeb L, Sevestre J, Mailhe M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M (2020) Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med Infect Dis 34:101663

Article  Google Scholar 

Grenha A, Seijo B, Remunán-López C (2005) Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci 25(4–5):427–37

Article  CAS  Google Scholar 

Grove J, Marsh M (2011) Host-pathogen interactions: the cell biology of receptor-mediated virus entry. J Cell Biol 195(7):1071–1082

Article  CAS  Google Scholar 

Gunathilake TMSU, Ching YC, Uyama H, Chuah CH (2021) Nanotherapeutics for treating coronavirus diseases. J Drug Deliv Sci Technol 64:102634. https://doi.org/10.1016/j.jddst.2021.102634

Article  CAS  Google Scholar 

Haasnoot J, Westerhout EM, Berkhout B (2007) RNA interference against viruses: strike and counterstrike. Nat Biotechnol 25(12):1435–43

Article  CAS  Google Scholar 

Han J, Zhao D, Li D, Wang X, Jin Z, Zhao K (2018) Polymer-based nanomaterials and applications for vaccines and drugs. Polymers 10:31. https://doi.org/10.3390/polym10010031

Article  CAS  Google Scholar 

Ioerger TR, O’Malley T, Liao R, Guinn KM, Hickey MJ, Mohaideen N, Murphy KC, Boshoff HIM, Mizrahi V, Rubin EJ, Sassetti CM, Barry CE, Sherman DR, Parish T, Sacchettini JC (2013) Identification of new drug targets and resistance mechanisms in mycobacterium tuberculosis. PLoS One 8:1–13. https://doi.org/10.1371/journal.pone.0075245

Article  CAS  Google Scholar 

Jain AK, Khar RK, Ahmed FJ, Diwan PV (2008) Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier. Eur J Pharm Biopharm 69(2):426–35

Article  CAS  Google Scholar 

Kamal MA, Jusko WJ (2004) Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays. J Clin Pharmacol 44(9):1034–1045

Article  CAS  Google Scholar 

Kamaly N, Yameen B, Wu J, Farokhzad OC (2016) Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev 116(4):2602–2663. https://doi.org/10.1021/acs.chemrev.5b00346

Article  CAS  Google Scholar 

Kumar V, Sharma N, Maitra SS (2017) In vitro and in vivo toxicity assessment of nanoparticles. Int Nano Lett 7:243–256. https://doi.org/10.1007/s40089-017-0221-3

Article  CAS  Google Scholar 

Kumar Malik D, Baboota S, Ahuja A, Hasan S, Ali J (2007) Recent advances in protein and peptide drug delivery systems. Curr Drug Deliv 4(2):141–51

Article  Google Scholar 

Lawrence MJ, Rees GD (2000) Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45(1):89–121. https://doi.org/10.1016/s0169-409x(00)00103-4

Article  CAS  Google Scholar 

Ledford H (2020) Chloroquine hype derails coronavirus drug trials. Nature 580(7805):573

Article  CAS  Google Scholar 

Ledford H (2020b) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature 582(7813):469. https://doi.org/10.1038/d41586-020-01824-5

Article  CAS  Google Scholar 

Lembo D, Cavalli R (2010) Nanoparticulate delivery systems for antiviral drugs. Antivir Chem Chemother 21(2):53–70

Article  CAS  Google Scholar 

Li ZZ, Wen LX, Shao L, Chen JF (2004) Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J Control Release 98(2):245–254. https://doi.org/10.1016/j.jconrel.2004.04.019

Article  CAS  Google Scholar 

Li L, Li R, Wu Z, Yang X, Zhao M, Liu J, Chen D (2020) Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care 10:1–9

Article  Google Scholar 

Li J, Zhang K, Wu D, Ren L, Chu X, Qin C, Han X, Hang T, Xu Y, Yang L, Yin L (2021) Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19. Asian J Pharm Sci 16(6):772–783. https://doi.org/10.1016/j.ajps.2021.09.002

Article  Google Scholar 

Liu J, Liao X, Qian S et al (2020) Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen China. Emerg Infect Dis 26(6):1320. https://doi.org/10.3201/eid2606.200239

Article  CAS  Google Scholar 

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet 395(10224):565–74

Article  CAS  Google Scholar 

Lythgoe MP, Middleton P (2020) Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci 41(6):363–382

Article  CAS  Google Scholar 

Maideen NM (2021) Therapeutic efficacy of kabasura kudineer (siddha formulation), in covid-19–a review of clinical and molecular docking studies. Asian J Adv Res 14:817–824

Google Scholar 

Malmsten M (2006) Soft drug delivery systems. Soft Matter 2(9):760–769

Article  CAS  Google Scholar 

Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, von Andrian U, Farokhzad OC (2010) Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (Lond) 5(2):269–85. https://doi.org/10.2217/nnm.10.1

Article  CAS  Google Scholar 

Maus A, Strait L, Zhu D (2021) Nanoparticles as delivery vehicles for antiviral therapeutic drugs. Eng Regen 2:31–46. https://doi.org/10.1016/j.engreg.2021.03.001

Article  Google Scholar 

Meuleman P, Catanese MT, Verhoye L, Desombere I, Farhoudi A, Jones CT, Sheahan T, Grzyb K, Cortese R, Rice CM, Leroux-Roels G (2012) A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spreadin vitroandin vivo. Hepatology 55(2):364–372

Article  CAS  Google Scholar 

Milovanovic M, Arsenijevic A, Milovanovic J, Kanjevac T, Arsenijevic N (2017) Nanoparticles in antiviral therapy. Antimicrobial nanoarchitectonics. Elsevier, Amsterdam, pp 383–410

Chapter  Google Scholar 

Mitchell MJ, Billingsley MM, Haley RM et al (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20:101–124. https://doi.org/10.1038/s41573-020-0090-8

Article  CAS